1Enger W, Chapel HM. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitis [J]. Clin Exp Immunol,1990,82: 244～249.
2Takizawa M. Clinical significance of antineutrophil cytoplasmic antibodies and pathogenetic role of adhesion molecules for Wegener' s granulomatosis[J]. Hokkaido Igaku Zasshi, 1996,71 (4): 517～529.
3Wang CR,Liu MF,Tsai RT,et al. Circulating intercellular adhesion molecules-1 and autoantibodies including antiendothelial cell, anti-cardioipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis[J]. Clin Rheumatol, 1993,12(3): 375～380.
4Michael C, Sneller MD, Anthony S, et al.Pathogenesis of vasculitis syndromes [J].Adv Rheumatol, 1997,81(1) :221～242.
5Van der woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes:tool for diagnosis and maker of disease activity in Wegener' s granulomations[J]. Clin Exp Immunol, 1989,78:143～148.
6Schultz DR,Tozman EC. Antineutrophil cytoplamic antibodies: major autoantigens,pathophysiology, and disease association[J]. Semin Arthritis Rheum, 1995,25 (3):143～159.
7Robertson CR, Mccallum RM. Changing concept in pathophysiology of the vasculitides [J]. Curr Opin Rheumatol, 1994, 6(1):3～10.
8Cid MC. New developments in the pathogenesis of systemic vasculitis[J]. Curr Opin Rheumatol, 1996,8(1): 1～11.
9Johnson PA, Alexander HD, Mcmillan SA,et al. Upregulation of the granulocyte adhesion molecule Mac-1 by antoantibodies in antoimmune vasculitis [J]. Clin Exp Immunol, 1997,107(3) :513～519.
10Johnson PA, Alexander HD, Mcmillan SA, et al. Upregulation of the adhension molecule intercellular adhesion molecule-1( ICAM-1 ) by autoantibodies in autoimmue vaculitis[J]. Clin Exp Immunol, 1997, 108(2) :234～242.
